National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry

Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents

(2015) Philip D. Home et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2014) Silvio E. Inzucchi et al.   DIABETES CARE

Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials

(2014) David R. Owens et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Changing disease trends in the Asia-Pacific

(2011) D. A. Tan   CLIMACTERIC

An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study

(2011) Philip Home et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review

(2011) S. Barendse et al.   DIABETIC MEDICINE

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia

(2011) Shih-Tzer TSAI et al.   Journal of Diabetes

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

(2010) S. G. Swinnen et al.   DIABETES CARE

Successes and challenges of insulin therapy for type 2 diabetes in a managed-care setting

(2009) Gregory A. Nichols et al.   CURRENT MEDICAL RESEARCH AND OPINION

Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study

(2009) L. F. Meneghini et al.   CURRENT MEDICAL RESEARCH AND OPINION

DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week Results: Safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

(2009) J. B. Buse et al.   DIABETES CARE

An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies

(2008) Mafauzy Mohamed et al.   CURRENT MEDICAL RESEARCH AND OPINION

Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study

(2008) A. Liebl et al.   CURRENT MEDICAL RESEARCH AND OPINION

Multifaceted Determinants for Achieving Glycemic Control: The International Diabetes Management Practice Study (IDMPS)

(2008) J. C.N. Chan et al.   DIABETES CARE

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study

(2008) D. Khutsoane et al.   DIABETES OBESITY & METABOLISM

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

(2008) J. Rosenstock et al.   DIABETOLOGIA

The IMPROVE™ study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts

(2008) P. Valensi et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

(2008) Jianping Weng et al.   LANCET

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE